Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis
CONCLUSION: This study evaluated the efficacy of GLP-1RAs in patients with NAFLD and NASH. These results suggest that GLP-1RAs may be a potential and viable therapeutic approach as a targeted agent to intervene in disease progression of NAFLD and NASH.PMID:38555202 | DOI:10.1016/j.pcd.2024.03.005
Source: Primary Care - Category: Primary Care Authors: Lixuan Fang Jine Li Haixia Zeng Jianping Liu Source Type: research
More News: Alcoholism | Byetta | Databases & Libraries | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Primary Care | Science | Statistics | Study | Urology & Nephrology | Victoza